NovaBay Pharmaceuticals Inc (NBY)
0.7198
+0.01
(+1.52%)
USD |
NYAM |
Nov 21, 16:00
0.7093
-0.01
(-1.46%)
After-Hours: 20:00
NovaBay Pharmaceuticals Shareholders Equity (Quarterly): 1.072M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.072M |
June 30, 2024 | -0.617M |
March 31, 2024 | 0.16M |
December 31, 2023 | 3.314M |
September 30, 2023 | 7.037M |
June 30, 2023 | 8.563M |
March 31, 2023 | 8.89M |
December 31, 2022 | 10.55M |
September 30, 2022 | 13.78M |
June 30, 2022 | 15.74M |
March 31, 2022 | 17.75M |
December 31, 2021 | 10.17M |
September 30, 2021 | 9.364M |
June 30, 2021 | 11.21M |
March 31, 2021 | 10.98M |
December 31, 2020 | 12.32M |
September 30, 2020 | 13.88M |
June 30, 2020 | 0.983M |
March 31, 2020 | -0.349M |
December 31, 2019 | 0.973M |
September 30, 2019 | 2.923M |
June 30, 2019 | 1.669M |
March 31, 2019 | 1.129M |
December 31, 2018 | 4.954M |
September 30, 2018 | 6.059M |
Date | Value |
---|---|
June 30, 2018 | 7.429M |
March 31, 2018 | 8.871M |
December 31, 2017 | 2.594M |
September 30, 2017 | 1.832M |
June 30, 2017 | 3.209M |
March 31, 2017 | 4.356M |
December 31, 2016 | 7.101M |
September 30, 2016 | 6.718M |
June 30, 2016 | -2.467M |
March 31, 2016 | -7.299M |
December 31, 2015 | -5.098M |
September 30, 2015 | 0.227M |
June 30, 2015 | 4.904M |
March 31, 2015 | 2.149M |
December 31, 2014 | 1.848M |
September 30, 2014 | 5.69M |
June 30, 2014 | 9.22M |
March 31, 2014 | 11.84M |
December 31, 2013 | 8.516M |
September 30, 2013 | 5.422M |
June 30, 2013 | 7.21M |
March 31, 2013 | 10.34M |
December 31, 2012 | 14.05M |
September 30, 2012 | 7.444M |
June 30, 2012 | 5.613M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.617M
Minimum
Jun 2024
17.75M
Maximum
Mar 2022
7.789M
Average
9.127M
Median
Shareholders Equity (Quarterly) Benchmarks
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Oragenics Inc | 3.078M |
Nanoviricides Inc | 10.11M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.877M |
Total Liabilities (Quarterly) | 2.805M |
Debt to Equity Ratio | 0.0476 |
Current Ratio | 1.149 |
Net Debt Paydown Yield | 6.74% |